LB PHARMACEUTICALS INC (LBRX)
Score window: Apr. 15, 2025 to Apr. 14, 2026
| Date | Form | Sentiment | Urgency | Summary | Open |
|---|---|---|---|---|---|
| Sep. 9, 2025 | CORRESP | Neutral/Informational | Moderate | LB Pharmaceuticals Inc has submitted a request to the SEC for the acceleration of the effective date of their Registration Statement on Form S-1. The company is seeking to have th… | Read Filing EDGAR |
| Sep. 9, 2025 | CORRESP | Neutral/Informational | Moderate | LB Pharmaceuticals Inc has submitted a request to the SEC to accelerate the effective date of their amended Registration Statement on Form S-1. The underwriters, represented by Le… | Read Filing EDGAR |
| Sep. 3, 2025 | CORRESP | Neutral/Informational | - | No summary returned. | Read Filing EDGAR |
| Aug. 22, 2025 | CORRESP | Neutral/Informational | Moderate | LB Pharmaceuticals Inc submitted a response to the SEC regarding comments on their Amendment No. 2 to the Draft Registration Statement on Form S-1. The correspondence addresses sp… | Read Filing EDGAR |
| Aug. 12, 2025 | UPLOAD | Concern from SEC | Moderate | The SEC has reviewed LB Pharmaceuticals Inc's amended draft registration statement and provided comments that require a response. They highlight the need for clearer disclosures r… | Read Filing EDGAR |